EMBC Embecta Corp.
$3.13 +1.13%
Healthcare · Surgical & Medical Instruments & Apparatus
Embecta Corp. (EMBC) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $186 million. Shares last traded at $3.13, 79.9% below their 52-week high. Over the past year the stock is down 68.2%. The shares yield 24.0% in dividends.
Market Cap
$186M
Shares Out
59.3M
EPS (TTM)
$2.99
P/E Ratio
1.05
P/S Ratio
—
P/B Ratio
—
Dividend / Share
$0.75
Dividend Yield
23.96%
52-Week High
$15.57
52-Week Low
$2.77
Volume
226,367
Avg Vol (3m)
98,876.381
Performance
1W
+1.95%
1M
+8.30%
3M
-65.60%
6M
-73.70%
YTD
-73.18%
1Y
-68.19%
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
RSI (14)
28.46
SMA (50)
$5.43
SMA (200)
$10.44
Price vs SMA50
-42.37%
Price vs SMA200
-70.03%
ATR (14)
$0.23
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q2 2026 | $0.67 | 2026-05-05 |
| Q1 2026 | $0.74 | 2026-02-05 |
| FY 2025 | $1.62 | 2025-11-25 |
| Q3 2025 | $1.18 | 2025-08-08 |
| Q2 2026 | $0.40 | 2026-05-05 |
| Q1 2026 | $0.00 | 2026-02-05 |
Surgical & Medical Instruments & Apparatus peers
EMBC vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.
1–14 of 14
| SYK | Stryker Corporation | $118.1B | 36.38 | 4.70 | 12.9% | +2.28% |
| MMM | 3M | $83.9B | 25.82 | 3.36 | 13.0% | +1.10% |
| BSX | Boston Scientific | $67.3B | 23.27 | 3.35 | 14.4% | +0.64% |
| BDX | Becton Dickinson | $39.7B | 23.64 | 1.82 | 7.7% | +1.62% |
| MDLN | Medline Inc. | $29.4B | — | — | — | -1.47% |
| DXCM | DexCom | $28.0B | 33.43 | 6.00 | 17.9% | +1.69% |
| RMD | ResMed | $27.4B | 19.53 | 5.32 | 27.2% | +1.24% |
| WST | West Pharmaceutical Services | $23.2B | 46.92 | 7.54 | 16.1% | +1.35% |
| SOLV | Solventum | $13.1B | — | — | — | +1.21% |
| PEN | Penumbra Inc | $12.5B | 70.18 | 8.88 | 12.7% | +0.28% |
| GMED | Globus Medical Inc | $10.8B | 19.99 | 3.66 | 18.3% | +5.00% |
| BAX | Baxter International | $10.3B | -10.74 | 0.91 | -8.5% | +2.58% |
| PODD | Insulet Corporation | $10.1B | 40.84 | 3.73 | 9.1% | +1.51% |
| GKOS | Glaukos Corp | $7.7B | -40.92 | 15.13 | -37.0% | +2.53% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.